Menu SECTIONS
  • News
  • Features
  • CME
  • Clinical Tools
  • Conferences
  • Special Collections
  • Multimedia
  • Diagnosis & Disease Info
  • Topics
    • Axial Spondyloarthritis
    • Connective Tissue Disease
    • Crystal Arthropathies
    • Diseases of Bone and Cartilage
    • General Medicine
    • General Rheumatology
    • Infection in Rheumatic Disease
    • Musculoskeletal Pain
    • Myositis
    • Osteoarthritis
    • Pediatric Rheumatology
    • Practice Management
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren Syndrome
    • Systemic Lupus Erythematosus
    • Vasculitis
  • Haymarket Medical Network
    • Cancer Therapy Advisor
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • MPR
    • Medical Bag
    • Neurology Advisor
    • Oncology Nurse Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
Part of the
  • News and Features
  • CME
  • Conferences
  • Clinical Tools
  • Special Collections
  • Multimedia

news
BASDAI and ASDAS Compared in Assessing Axial Involvement in Patients With PsA

Researchers conducted a post hoc analysis to compare the performance of 2 disease activity scores — BASDAI and ASDAS — in assessing axial involvement in patients with PsA receiving treatment with guselkumab.

Publish Date November 16, 2022
news
Deucravacitinib Shows Sustained Clinical Efficacy in Patients With Active SLE

The safety and efficacy of deucravacitinib in active SLE was assessed in a randomized placebo-controlled trial presented at ACR Convergence 2022.

Publish Date November 16, 2022
news
Heel Enthesitis in axSpA Associated With Worse Scores on Outcome Measures

Researchers studied the prevalence of heel enthesitis in axial spondyloarthritis and assessed its impact on outcome measures after a 2-year follow-up.

Publish Date November 16, 2022
news
Study Results Support COVID-19 Vaccination in Pregnant Women With Rheumatic Disease

Researchers described the obstetric outcomes, based on COVID-19 vaccination status, in pregnant women with rheumatic and musculoskeletal diseases.

Publish Date November 16, 2022
news
Micro-RNA Signature May Be Important Biomarker for Hand Osteoarthritis

The role of micro-RNAs in the pathophysiology of hand osteoarthritis was explored, using data from postmenopausal women.

Publish Date November 16, 2022
news
Pegloticase Combined With Methotrexate Maintains Efficacy for Gout at Year 1

Presenting at ACR 2022, researchers assessed the safety and efficacy of pegloticase with add-on methotrexate vs placebo for uncontrolled gout.

Publish Date November 15, 2022
news
How Does Risk for CV Events Differ Between Tofacitinib and TNFi in RA?

A post hoc analysis was conducted to compare the risk for cardiovascular events between treatment with tofacitinib and TNF inhibitors among patients with RA.

Publish Date November 15, 2022
news
Patients on Low-Dose Glucocorticoids Should Receive Anti-Osteoporotic Therapy

Researchers assessed the risks and benefits of glucocorticoids in women with inflammatory rheumatic musculoskeletal diseases.

Publish Date November 15, 2022
news
One-Year Retention High With Infliximab Biosimilar Switching in Inflammatory Arthritis

Using the DANBIO registry, the effectiveness of infliximab biosimilar switching was assessed among patients with inflammatory arthritis.

Publish Date November 15, 2022
news
How Did the Roe v Wade Overturn Affect Methotrexate Access in Rheumatic Disease?

The aim of the study was to evaluate the effect of the Roe v Wade decision on methotrexate access among patients with rheumatic disease.

Publish Date November 15, 2022
news
Secukinumab and Adalimumab Biosimilar Comparable for Treating Radiographic Progression in axSpA

Researchers conducted a head-to-head trial that compared the effect of secukinumab and adalimumab biosimilar on spinal radiographic progression in axial spondyloarthritis.

Publish Date November 14, 2022
news
Corticosteroids or Immunosuppressive Therapy Tapering Increases Flares in Stable SLE

Researchers assessed the effect of tapering of corticosteroids or immunosuppressive therapy on disease activity, flare rate, and remission among patients with stable systemic lupus erythematosus.

Publish Date November 14, 2022
news
Early Upadacitinib Response Predicts Long-Term Rheumatoid Arthritis Outcomes

Researchers conducted a post hoc analysis to determine the effect of early response to upadacitinib on long-term clinical outcomes in rheumatoid arthritis.

Publish Date November 14, 2022
news
Monthly ULT Titration Improves Serum Uric Acid Levels, Ultrasound Features in Gout

The TICOG study was conducted to compare monthly urate-lowering therapy titration and conventional treatment in achieving and maintaining optimal serum uric acid levels in gout.

Publish Date November 14, 2022
news
Weak Association Observed Between Systemic Vasculitis and Myocardial Infarction

Using data from the National Inpatient Sample, the association between systemic vasculitis and myocardial infarction was reported.

Publish Date November 14, 2022
news
Concomitant Initiation of csDMARDs and bDMARDs Increases Remission Rates in JIA

Study investigators compared the effectiveness of 3 consensus treatment plans to achieve clinically inactive disease in patients with untreated polyarticular juvenile idiopathic arthritis (pJIA).

Publish Date November 11, 2022
news
Rituximab, Cyclophosphamide Beneficial for Treating Connective Tissue Disease-Related ILD

Researchers assessed the efficacy of rituximab and cyclophosphamide in the treatment of mixed connective tissue disease-related interstitial lung disease.

Publish Date November 11, 2022
news
New Causal Genes, Pathways Implicated in Gout Pathogenesis

Researchers presented a gout genome-wide association study (GWAS) to identify genes and pathways that enable the progression of hyperuricemia to gout.

Publish Date November 11, 2022
news
Safety, Efficacy of Sarilumab in Relapsing Polymyalgia Rheumatica Assessed

In a phase 3 trial, researchers studied the safety and efficacy of sarilumab among patients with relapsing polymyalgia rheumatica.

Publish Date November 11, 2022
news
Diet and Exercise Significantly Reduce Knee Osteoarthritis Pain

Researchers determined the effect of a weight loss and exercise program on knee pain among patients with knee osteoarthritis, overweight, and obesity.

Publish Date November 11, 2022
  • Latest News Your top articles for Thursday

    For More Personalized News
  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

    • ABOUT
    • ADVERTISE
    • CONNECT
    Remarkable healthcare content
    Cancer Therapy Advisor
    Clinical Advisor
    Clinical Pain Advisor
    Dermatology Advisor
    Endocrinology Advisor
    Gastroenterology Advisor
    Hematology Advisor
    Infectious Disease Advisor
    MPR
    McKnight’s Home Care
    McKnight’s Long-term Care
    McKnight’s Senior Living
    Medical Bag
    Neurology Advisor
    Oncology Nurse Advisor
    Ophthalmology Advisor
    Optometry Advisor
    Psychiatry Advisor
    Pulmonology Advisor
    Rare Disease Advisor
    Renal and Urology News
    Rheumatology Advisor
    The Cardiology Advisor
    myCME

    Copyright © 2023 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

    Loading...
    Loading...